Literature DB >> 25728070

Role of rhinovirus load in the upper respiratory tract and severity of symptoms in lung transplant recipients.

Juan Ambrosioni1, Pierre-Olivier Bridevaux2, John-David Aubert3, Paola Soccal4, Ghislaine Wagner5, Laurent Kaiser6.   

Abstract

BACKGROUND: Rhinovirus is the most common cause of respiratory viral infections and leads to frequent respiratory symptoms in lung transplant recipients. However, it remains unknown whether the rhinovirus load correlates with the severity of symptoms.
OBJECTIVES: This study aimed to better characterize the pathogenesis of rhinoviral infection and the way in which viral load correlates with symptoms. STUDY
DESIGN: We assessed rhinovirus load in positive upper respiratory specimens of patients enrolled prospectively in a cohort of 116 lung transplant recipients. Rhinovirus load was quantified according to a validated in-house, real-time, reverse transcription polymerase chain reaction in pooled nasopharyngeal and pharyngeal swabs. Symptoms were recorded in a standardised case report form completed at each screening/routine follow-up visit, or during any emergency visit occurring during the 3-year study.
RESULTS: Rhinovirus infections were very frequent, including in asymptomatic patients not seeking a specific medical consultation. Rhinovirus load ranged between 4.1 and 8.3 log copies/ml according to the type of visit and clinical presentation. Patients with highest symptom scores tended to have higher viral loads, particularly those presenting systemic symptoms. When considering symptoms individually, rhinovirus load was significantly higher in the presence of symptoms such as sore throat, fever, sputum production, cough, and fatigue. There was no association between tacrolimus levels and rhinovirus load.
CONCLUSIONS: Rhinovirus infections are very frequent in lung transplant recipients and rhinoviral load in the upper respiratory tract is relatively high even in asymptomatic patients. Patients with the highest symptom scores tend to have a higher rhinovirus load.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HRV; Lung transplant recipient; Rhinovirus; Tacrolimus; Viral load

Mesh:

Substances:

Year:  2015        PMID: 25728070     DOI: 10.1016/j.jcv.2014.12.021

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  9 in total

1.  Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury.

Authors:  Katrina Bazemore; Michael Rohly; Nitipong Permpalung; Kai Yu; Irina Timofte; A Whitney Brown; Jonathan Orens; Aldo Iacono; Steven D Nathan; Robin K Avery; Hannah Valantine; Sean Agbor-Enoh; Pali D Shah
Journal:  J Heart Lung Transplant       Date:  2021-05-30       Impact factor: 10.247

2.  Genotyping of human rhinovirus in adult patients with acute respiratory infections identified predominant infections of genotype A21.

Authors:  Lili Ren; Donghong Yang; Xianwen Ren; Mingkun Li; Xinlin Mu; Qi Wang; Jie Cao; Ke Hu; Chunliang Yan; Hongwei Fan; Xiangxin Li; Yusheng Chen; Ruiqin Wang; Fucheng An; Shuchang An; Ming Luo; Ying Wang; Yan Xiao; Zichun Xiang; Yan Xiao; Li Li; Fang Huang; Qi Jin; Zhancheng Gao; Jianwei Wang
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

3.  Human Rhinovirus Infections in Hematopoietic Cell Transplant Recipients: Risk Score for Progression to Lower Respiratory Tract Infection.

Authors:  Alpana Waghmare; Hu Xie; Jane Kuypers; Mohamed L Sorror; Keith R Jerome; Janet A Englund; Michael Boeckh; Wendy M Leisenring
Journal:  Biol Blood Marrow Transplant       Date:  2018-12-08       Impact factor: 5.742

Review 4.  Respiratory Viruses in Solid Organ Transplant Recipients.

Authors:  Roni Bitterman; Deepali Kumar
Journal:  Viruses       Date:  2021-10-25       Impact factor: 5.048

5.  Late viral or bacterial respiratory infections in lung transplanted patients: impact on respiratory function.

Authors:  Marie Dubert; Benoit Visseaux; André Birgy; Pierre Mordant; Anne-Cécile Metivier; Gaelle Dauriat; Nadhira Fidouh; Yazdan Yazdanpanah; Nathalie Grall; Yves Castier; Hervé Mal; Gabriel Thabut; François-Xavier Lescure
Journal:  BMC Infect Dis       Date:  2020-02-24       Impact factor: 3.090

6.  Clinical, virological and epidemiological characteristics of rhinovirus infections in early childhood: A comparison between non-hospitalised and hospitalised children.

Authors:  Andrea H L Bruning; Xiomara V Thomas; Lonneke van der Linden; Joanne G Wildenbeest; René P Minnaar; Rogier R Jansen; Menno D de Jong; Peter J Sterk; Marc P van der Schee; Katja C Wolthers; Dasja Pajkrt
Journal:  J Clin Virol       Date:  2015-11-10       Impact factor: 3.168

Review 7.  Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management.

Authors:  Nancy Law; Deepali Kumar
Journal:  Drugs Aging       Date:  2017-10       Impact factor: 3.923

8.  Suspension microarray-based comparison of oropharyngeal swab and bronchoalveolar lavage fluid for pathogen identification in young children hospitalized with respiratory tract infection.

Authors:  Zhan-Ying Ma; Hua Deng; Li-Dong Hua; Wen Lei; Chang-Bin Zhang; Qi-Qiang Dai; Wei-Jing Tao; Liang Zhang
Journal:  BMC Infect Dis       Date:  2020-02-22       Impact factor: 3.090

9.  Epidemiology of the Rhinovirus (RV) in African and Southeast Asian Children: A Case-Control Pneumonia Etiology Study.

Authors:  Vicky L Baillie; David P Moore; Azwifarwi Mathunjwa; Henry C Baggett; Abdullah Brooks; Daniel R Feikin; Laura L Hammitt; Stephen R C Howie; Maria Deloria Knoll; Karen L Kotloff; Orin S Levine; Katherine L O'Brien; Anthony G Scott; Donald M Thea; Martin Antonio; Juliet O Awori; Amanda J Driscoll; Nicholas S S Fancourt; Melissa M Higdon; Ruth A Karron; Susan C Morpeth; Justin M Mulindwa; David R Murdoch; Daniel E Park; Christine Prosperi; Mohammed Ziaur Rahman; Mustafizur Rahman; Rasheed A Salaudeen; Pongpun Sawatwong; Somwe Wa Somwe; Samba O Sow; Milagritos D Tapia; Eric A F Simões; Shabir A Madhi
Journal:  Viruses       Date:  2021-06-27       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.